about
Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass graftingBiomarkers in heart failure with preserved ejection fractionThe kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'Innovative Therapeutics: Designer Natriuretic Peptides.High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies.Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.The role of B-type and other natriuretic peptides in health and disease.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence.N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohortPlasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury.Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis.Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomesRacial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study.Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volumeComparative transcriptome analysis on the alteration of gene expression in ayu (Plecoglossus altivelis) larvae associated with salinity change.Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.Molecular and physiological effects of nesiritideInduction of early biomarkers in a thrombus-induced sheep model of ischemic heart failurePharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction.Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction.Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women.ALDO-DHF & ParamountB-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.Changes in hypothalamus-pituitary-adrenal axis following transient ischemic attack.Value of plasma brain natriuretic peptide levels for predicting postoperative atrial fibrillation: a systemic review and meta-analysis.What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.The human endolymphatic sac expresses natriuretic peptides.An amyloidogenic determinant in N-terminal pro-brain natriuretic peptide (NT-proBNP): Implications for cardiac amyloidoses.Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection.Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan.
P2860
Q24644704-1E3AF4A1-DE43-4506-8D04-CFF2C0B8CCA6Q26768192-90C889B3-8FCF-4EE5-B7C6-B836081E7182Q27011043-F041ABDB-0352-4C3B-9FB7-19F27A68AD08Q33653332-3B82BBE0-1163-44A5-B003-F174B0F15B74Q34446778-F8CD0F76-B839-4D0B-9FA3-48536DF9A3B9Q34492413-347510DA-0C59-4B7E-918B-C611C03A63D1Q34501952-2095E940-5D3B-427B-B0E4-8FB0F9F5DE3BQ34566491-5BA70175-C269-4FCD-9274-5A23296AC77CQ34572109-1BB71514-9587-499C-B0DF-2F01C4518FAEQ35139977-E8CAC684-33F1-4CB5-97BC-49B72DEF4321Q35153971-8C4BDAD3-6431-44D8-82F2-FA6BE85B3E34Q35219570-AE21AE48-8B8C-4FB5-BBFB-C079B89A6D1EQ35387004-05602ABF-404C-4019-AC6D-6CA05A8026FFQ35508766-16402A93-C4C2-41F2-A071-E09771B406EEQ35574190-98432519-03DD-404B-8674-A7A5137D7F42Q35627261-14539C1D-3DEF-4134-935D-DD41E3E90CB3Q35869826-94E1BCE1-1C5B-44F9-94A8-D64B651FD4EFQ35925266-030B21BF-75CC-4E96-BFCC-13FE04B5FA05Q36141360-D5955546-9D57-4D1A-B586-8219F6FDB319Q36501539-2EC4ADD4-E221-467C-8469-9DD3ACF71E43Q37022997-D660CD3C-B522-4ED8-955B-44B56A27B177Q37182338-46124006-5E1D-413F-A39C-1991CAD697B3Q37217345-F330D5A6-5F5E-4067-BEC7-17095AF623E9Q37369965-EC2D0463-C5AB-4460-8DD3-1AB2CC5745BDQ37412804-373202B1-07DB-4499-8BC9-09065BE7DA0EQ37423205-BDBBCC85-BA99-4ABC-8DE1-870088DC71C7Q37463142-11973F6F-8430-4827-A1E3-40B175299393Q37468738-DC88C3C7-D508-4FCB-B2B9-60484C476D87Q37659171-1316354D-02E1-4E79-95C0-58F0F302AB8CQ37734430-6258194D-8A32-4C61-A286-21482822D78CQ37873387-586FD677-A536-4876-B8AC-434EA004750AQ38142904-F1D28EEF-4883-4487-8928-20D0C075C62CQ38152986-4DEEA765-1D82-4495-8EA0-30479EE2D185Q38365338-C8ED5F7D-B893-425F-87AD-F6A6E61C4A39Q38837698-9866C532-6F0B-4FE7-BD2D-859AE063C8EFQ38906947-7209389E-A0CA-460D-A935-98B0B5A4A080Q39724371-8287E238-3990-409B-B884-8B78EC688C21Q40222240-4450CFF4-3E0A-4AA0-80F5-EE2BFD8A3083Q41548532-47351FCD-FE62-4C89-8F34-2170616B3BF2Q41549636-4E99D19E-059B-4B0A-8789-16DAA3E4A2C2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biology of the natriuretic peptides.
@en
Biology of the natriuretic peptides.
@nl
type
label
Biology of the natriuretic peptides.
@en
Biology of the natriuretic peptides.
@nl
prefLabel
Biology of the natriuretic peptides.
@en
Biology of the natriuretic peptides.
@nl
P2093
P1476
Biology of the natriuretic peptides.
@en
P2093
A Mark Richards
Abelardo Martinez-Rumayor
John C Burnett
P356
10.1016/J.AMJCARD.2007.11.012
P407
P577
2008-02-01T00:00:00Z